• Breaking News

    Saturday, November 30, 2019

    Home Unlabelled Stocks - Some interesting news in the stock market this week

    Stocks - Some interesting news in the stock market this week

    November 30, 2019

    Stocks - Some interesting news in the stock market this week

    Some interesting news in the stock market this week

    Posted: 30 Nov 2019 03:10 AM PST

    The week began with Uber being banned from the city of London on Monday after a number of safety issues were identified. Uber can continue to operate while it appeals the decision but the move may yet (worryingly) lead to other cities withdrawing its license. Then, on Wednesday, Deere & Company revealed a horrendous outlook for construction industry with a 15% drop in sales expected. However, appropriately for the week of Cyber Friday, it was retail stocks that provided some good news with Burlington Stores, Best Buy and Dick's Sporting Goods all reporting beats and raising guidance on Tuesday.

    Burlington Stores showed how "off price" and "treasure hunt" retailers can thrive even while more traditional outlets continue to suffer. In fact they seem to be benefitting from the retail apocalypse as they offer a useful way for producers and brands to offload excess inventory. Expectations were already high but Burlington thrashed them with sales up 8.6%, Q3 EPS of $1.55 smashed consensus forecasts of $1.40 and the company raised full-year 2019 EPS guidance to a range of $7.28 to $7.33 per share from $7.14 to $7.22.

    Best Buy also reported a significant beat and raised full year EPS guidance to a range of $5.81 to $5.91 from $5.60 to $5.75 (and compared to $5.32 last year). Some commentators said Best Buy is emerging as the poster child for how to survive and thrive in a post Amazon world. In particular the company announced that it planned to offer next-day delivery on thousands of items, customers will able to pick up products in store within an hour of placing an order and the retailer also launched hundreds of alternative pickup locations in areas where there was no convenient store location. "We are excited about our holiday plans," said Corie Barry, newly appointed Best Buy CEO, "Our teams have once again put together a best-in-class assortment, prepared an amazing set of deals and ensured we have great inventory availability."

    Dick's Sporting Goods beat top and bottom estimates and raised guidance for the full year. The company has benefited from strategic initiatives that have focussed on better performing categories, more premium footwear offerings, faster e-commerce delivery times and investment in in-store experiences. Net sales were up 5%, same-store sales were up 6% beating expectations for growth of 2.9% and adjusted EPS was $0.52 compared to consensus forecasts of $0.38. Full year guidance EPS was raised to a range of $3.50 to $3.60 from $3.30 to $3.45 previously and compare to $3.24 last year.

    CEO Ed Stack said the company had seen increases in both the average shopping ticket and in the number of transactions during the third quarter and added "as we head into the holiday season, we remain very enthusiastic about our business".

    ​

    ​

    Growth stocks (Keysight, Nutanix and Ambarella )

    Keysight Technologies delivered a very strong finish to the year on Tuesday with both revenue and earnings exceeding the high-end of guidance for the quarter while full year EPS increased 46% to $4.72.

    Keysight is the leading provider of network test equipment to telecom operators and other OEMs and has benefitted from increasing demand for 5G test equipment. That's not expected to change with the wireless network test equipment market expected to grow almost 50% by 2023. Additionally it is seen as an agnostic way to benefit from the boom with no single customer making up more than 10% of total revenue.

    Ron Nersesian, Chairman and CEO, said on the call this week "we are well-positioned for continued growth with a broad and differentiated portfolio of solutions targeted at the fastest growing segments of our end-markets. Our focus on the long-term secular growth rate trends in 5G, next-generation auto, networking, IoT, and defense modernization give us confidence in our ability to drive above-market growth even in times of macroeconomic uncertainty."

    The stock price took it in its stride, increasing only 1 or 2%, even after Citi said that Keysight remained its top stock pick. Perhaps that is due to weariness given the stock has already climbed almost 90% this year. However the valuation doesn't look expensive on 23x trailing earnings with earnings growth of 46% and a very bright medium term outlook.

    ​

    There are a couple of reasons why Nutanix stock is up 20% since reporting mediocre sales growth and an increase in losses

    The cloud computing software company's move (a couple of years ago) to a software centric rather than hardware centric model has hit the top and the bottom line but the higher margin business looks like it will pay off in the long run.

    The market has had a mixed reaction to recent earnings reports but its reaction to this weeks announcement has been well received with the stock up 20%. That's despite revenue of $314.8 million increasing only marginally from $313.3 million and GAAP net loss per share of $1.21 more than doubling from $0.54 last year.

    That's probably due to two reasons.

    1. Deferred revenue of $975.3 million was up 39%. This relates to the software services which Nutanix has not yet provided. It shows that the new software subscriptions business is growing quickly even though that is not apparent from the total revenue figures.

    2. Non-GAAP gross margin of 80.1%, up from 78.6% in the first quarter of fiscal 2019 and way ahead of the 62.6% non-GAAP gross margin reported by Nutanix in Q4 of fiscal 2017. That shows that the new software model is way more profitable than the old one.

    In short the new business is highly profitable and growing quickly. A good combination.

    The stock is valued at about 5.1x current year revenues which looks reasonable compared to the growth and profitability of the software business. Additionally analysts expect that software sales will start driving top line growth of 27% next year which should allow similar stock price growth even without multiple expansion.

    ​

    Ambarella was up on Monday after strong results with Q3 revenues increased 18.6% and adjusted EPS of $0.32 compared to $0.21 last year and beat forecasts by about 12 cents. However it was the continuing progress with Computer Vision (CV) that was the real driver of optimism. The results were good but on a valuation of 8x revenues and 90x forecast earnings they need to be.

    Ambarella originally rode on the back of GoPro until GoPro faded and Amabarella had to quickly adapt. Investments in 2018 led to CV Becoming the target market with huge opportunities in security and autos.

    It is that optimism that is driving Ambarella's 57% gains this year. The market cap currently stands at $1.81 billion against a market opportunity estimated at $18 billion and growing by 8% p.a.

    As Fermi Wang, Chief Executive Officer, said in the Q2 conference call

    "In summary, we're just starting to realize our vision to enable big data analytics in video HD endpoint devices or AI in the camera. As this play out, we expect to see multi-billion dollar increases in our addressable market."

    That said, there are still plenty of risks with numerous competitors looking to commoditize the business. Additionally trade talks with China could also scupper Amabarella's vision.

    For me the valuation looks fair, after strong gains this year, a lot of the positive outlook is already built in while downside risks remain significant.

    ​

    ​

    Value stocks (Dycom and Cymabay)

    Dycom reported results on Tuesday with revenues up 4.7% while earnings fell 10%. A mixed result perhaps but the drop in earnings was due to a large and complex customer contract previously flagged in other calls that has added to costs and hit gross margins. Encouragingly that troublesome program is now ramping down and will finish by April next year.

    Dycom is the leading provider of specialty contracting services for telecommunications net work operators in the United States. You have probably seen Dycom's crews working along roadways stringing cable or burying underground fiber. Customers include Verizon at 20.6% of total revenue, CenturyLink at 18.6% of revenue, AT&T at 18.4% of revenue, Comcast 14.9% of revenue and finally Windstream at 4.8% of revenue.

    As a result Dycom has benefitted from strong tailwinds from the huge investment that has gone into connectivity infrastructure. Over the past decade the company has delivered strong long-term growth, including 10% top line growth and double digit EPS gains. That's not expected to change with 5G deployments driving growth for years to come.

    On the earnings call Steven E. Nielsen, President and Chief Executive Officer, made several encouraging statements. In particular I found this one encouraging, "We believe wireline deployments are the foundational element of what is expected to be a decades long deployment of fully converged wireless/wireline networks that will enable high bandwidth, low latency 5G applications."

    The stock looks cheap with such a bright outlook for growth and a valuation of just 5.3x current year EBITDA. Profitability metrics have been muddied by the troublesome contract discussed but, with that falling off early next year, profits are forecast to jump 20% and grow 14% p.a. thereafter. That provides an attractive PE of 18x forward earnings.

    ​

    Cymabay Therapeutics down 70% after it scrapped late stage studies for its experimental drug for multiple liver disease indications.

    It is a disastrous outcome for the company but with a market cap of $121 million compared to cash balances of $219 million, zero debt and total liabilities of $19 million -- it seems there is $79 million of cash that has been completely written off. In short the stock is valued at 55% of net cash following the drop.

    ​

    ​

    Highly Speculative (Toughbuilt Industries and My Size Inc)

    On Tuesday ToughBuilt Industries (warning high risk nano cap with market capitalization of just $5.7 million), the designer, manufacturer and distributor of innovative tools and accessories to the building industry, jumped 50% after reporting that its U.S. and Canadian Amazon storefronts had sales in the initial seven months of operation in excess of $1.8 million. Equivalent to an annualized run-rate of $3.5 million, which is 40% higher than the run rate announced in May 2019 by the Company.

    That's a significant amount for a company that reported sales of $15.3 million last year and the market took heart that ToughBuilt could continue to increase sales with a gradual increase of product offerings to the Amazon storefronts and with products also being sold globally on its Amazon storefronts throughout Europe, Australia and other international destinations.

    Encouragingly, Michael Panosian, Chief Executive Officer of ToughBuilt, commented, "The initial seven months of operation of our North American storefronts has well exceeded expectations. In fact, we seem to be on an even greater upward trajectory in the fourth quarter and should continue an annualized basis."

    The stock has since given back a significant portion of those gains but remains up 23%.

    ​

    My Size Inc (warning high risk nano cap with market capitalization of just $7.2 million) spiked higher on Wednesday (before falling back) after the company reported that it had secured a commercial contract with a leading Turkish apparel company (AY Marka Mağazacılık A.Ş).

    It's the latest in a series of positive announcements for the company since it was awarded a patent last year for its smartphone measurement technology. The company's app, MySizeID, allows customers to quickly and accurately measure themselves using their smartphone, pick the store or brand they want to shop and then find which sizes fit perfectly. That allows an improved and personalized shopping experience for customers but also allows retailers to save on size related returns which can be material.

    Despite the good news, this tiny company is running out of cash and I expect a secondary offering in Q1 next year which will be highly dilutive. It might be better to wait to see those terms before making a decision on this high risk opportunity.

    ​

    ​

    Insider (Matinas and Assured Guarantee)

    On Monday, both the CFO and Vice Chairman at Matinas BioPharma made $100,000+ purchases of stock. Matinas is an interesting company that has a prescription-only omega-3 fatty acid-based composition (similar to Vascepa) under development for reducing triglycerides (named MAT9001). Importantly it has shown superiority versus Amarin's Vascepa for the same indications..

    Amarin's stock has risen 10x over the past year as it has successfully progressed towards approval for Vascepa. Most recently an FDA expert panel unanimously to recommend Amarin's Vascepa for reducing the risk of cardiovascular events including heart attack and stroke.

    However back in 2015, Matinas was conducting a phase I trial of its own omega 3 drug MAT9001, comparing it directly with Vascepa. It found that MAT9001 was much more effective than Vascepa at reducing triglycerides and VLDL-C. MAT9001 saw a 33.2% reduction from baseline versus 10.5% for Vascepa, and VLDL-C reduction was at 32.5% versus 8.1% for Vascepa. Despite that trial's success, Matinas put MAT9001 on the backburner while it used its resources to develop its lead antifungal candidate.

    The company has since revived MAT9001 with a 100-patient Phase II crossover head-to-head trial against Vascepa on patients with high triglycerides that will begin dosing next quarter, with results expected by the end of 2020.

    There is no guarantee that it will succeed and even if it does the approval process will probably take a while. However the results so far are encouraging and the insider purchases send a clear signal that senior management is confident in success.

    The stock price has increased almost 100% but, with a market valuation of just $200 million compared to $7.63 billion for Amarin, there could be a lot more upside for investors who join the CFO and Vice Chairman.

    ​

    More insider buying at Assured Guarantee Ltd as Chief Investment Officer, Andrew Feldstein, purchase another $1.9 million of stock this week. That brings the total number of purchases over the past 2 months to 20.

    The company is a monoline guarantor that insures municipal and structured debt issuance. It ran into trouble during the great recession but has staged something of a recovery and Mr Feldstein seems to be highly confident in its future.

    Two points of interest that caught my eye;

    1. The company estimates it's non GAAP adjusted book value at $90.18 compared to Fridays close at $49.65 (GAAP valuation of $68.94 also compares well)

    2. The company CEO said on the Q2 earnings call that he believed the firm had $3.2 billion of excess capital beyond what was required to maintain its AAA rating. A meaningful amount for a company with a market capitalization of $4.7 billion.

    ​

    ​

    Pharmaceutical (Sorrento Therapeutics)

    Sorrento Therapeutics up 84% after positive signals from those in the know

    Maybe I am reading too much into it but;

    - the company approached a number of potential biotech companies to discuss commercial partnership opportunities

    - it seems that 2 of the companies approached were so impressed that they have submitted bids between $3-$5 which were 88% to 213% above Friday's close

    - Sorrento have immediately declined the offers saying "the offer significantly undervalued Sorrento and was not in the best interest of the Company's stockholders."

    I am not an expert on the company. I can see it has a number of commercial and late stage non-opioid pain therapies as well as four immuno-oncology (treatments that use the body's immune system to fight cancer) programs in development. Management as usual believe that these have a great outlook for growth. To be fair the non-opioid market is expected to grow from $4 billion to $9 billion over the next 10 years and I have to say it looks like an exciting opportunity for Sorrento with numerous therapies and a market cap of just $480 million (after the recent increase).

    However it is the apparent enthusiasm by two unrelated outsiders to make an unsolicited bid having seen (I assume) Sorrento's plans for development that is key for me.

    The stock is currently valued at $2.92. That is lower than both the rejected bids of $3 and $5, two analyst target prices of $21 and $28 and represents a valuation that is approximately 12% of the fast growing non-opioid therapy target market.

    It is often difficult to judge individuals motivations but when two operators in the sector get inside information and put in a bid at prices above the current price it sends a strong signal that the company is undervalued.

    ​

    "FOLLOW" me if you would like to see my regular updates during the week.

    This is not a recommendation to buy or sell. Stocks are risky and not suitable for everybody. Some of the stocks mentioned are HIGH RISK AND SPECULATIVE. Please do your own research.

    submitted by /u/InterestingNews1
    [link] [comments]

    Wall Street Week Ahead for the trading week beginning December 2nd, 2019

    Posted: 30 Nov 2019 09:24 AM PST

    Good Saturday morning to all of you here on r/stocks. I hope everyone on this sub made out pretty nicely in the market this past week, and is ready for the new trading week and month ahead.

    Here is everything you need to know to get you ready for the trading week beginning December 2nd, 2019.

    Markets may get a boost from cheery Black Friday consumer sentiment, seasonal strength - (Source)

    Stocks have had a bang-up year so far, and they're heading straight into the month that is often the best of all.

    The S&P 500 is up more than 25% for the year. Thanksgiving week was technically positive for the market, with the small cap Russell 2000 breaking out, joining other indexes in an uptrend.

    Stocks, however, were lower Friday in sluggish trading after the Thanksgiving holiday. Through Wednesday, the Dow, Nasdaq and S&P 500 had all popped to new record highs, with consumer discretionary and tech names leading the market higher this past week. The Russell 2000 is not yet back to its highs, but it pushed above its previous 52-week high, in a healthy sign for the overall market.

    In the coming week, investor focus will move more intently to the topic of trade, and that is what will make or break the rally at year-end.

    President Donald Trump has promised that a preliminary trade deal with China is close, but there still is no agreement and the Dec.15 deadline for new tariffs is getting closer. Trump's signing of legislation Wednesday supporting the Hong Kong protesters drew a negative reaction from Beijing and adds more uncertainty to trade talks.

    The health of the economy is also a factor for markets, and there is some key data, with the ISM manufacturing report on Monday followed by the government's all-important monthly jobs data on Friday.

    Best month of year

    2019 has turned out to be a very good year for the market, with the Jan. 1 to Thanksgiving Day period the 14th best for the S&P 500 since 1928, according to Bespoke. The 25.5% gain in the S&P 500 was the best for the period since 2013, and now the market enters a typically strong period.

    "December is the best month of the year. The S&P is up 1.6 percent on average. It also has the highest frequency of advances, up 76% of the time," said Sam Stovall, chief investment strategist at CFRA. December is also the least volatile month of all, but it could see some bumps.

    "The market tends to go through a mid-December low, which then represents a good buying opportunity, at least through the end of January," Stovall said, adding he thinks the decline would be no more than 5%. "I don't think we need a big pullback or a correction. A mid-single digit decline would be sufficient."

    Stovall said 2019 was set up to win because of the way the year started, following the sharp sell-off last December. When the months of January and February are higher, the S&P 500 has an average total return of 24%, according to data going back to 1945. If the following year does not see have a similar double gain in January and February, it still does fairly well with a normal average return of 8% to 9%, he said.

    The market's performance for the entire year also bodes well for a positive move into year-end, according to Bespoke. Since 1928, when stocks are up 20% or more by Thanksgiving, like this year, the S&P 500 usually ends the year even higher, with an average gain of 1.8% between Black Friday and New Year's Eve, Bespoke noted.

    S&P Sub-industry sector performance

    Stovall also looked at sector performance for December, going back to 1995 and found that some of the worst performing S&P sub-industry sectors were retail oriented and are highly dependent on good holiday sales. On average, computer and electronics retailers were weakest, off 4.5%, followed by leisure products off 2.2% and department stores, off 0.9%. Specialty stores and apparel and luxury goods were also among the 10 poorest performers.

    While 87% of the sub-industry sectors were positive, the top performer was homebuilding, up 4.5 %, followed by home improvement retail.

    "You want to buy now what nobody wants to own," said Stovall, noting the market is forward pricing so investors are looking ahead to building activity picking up in spring and summer when they dip into homebuilders. Companies that sell fertilizers also do well in December.

    Stocks on Friday closed out their best monthly performance since June. The S&P 500 was up 3.4% to 3,140, and the Dow closed Friday at 28,051, up 3.7% for the month of November.

    Technology was the best performing sector for the month, gaining 5.2%. That helped drive the Nasdaq up 4.5% for the month to 8,665.

    Biotech was also a top performer, helping lift the Russell 2000, which gained 4% in November to 1,624. The IBB iShares Nasdaq Biotechnology ETF was up 11% for the month.

    Trade tensions

    The big risk to the market in December is the outcome of trade talks, but economic reports will be important as investors continue to assess whether the Fed was right in ending its rate cuts.

    The economy has shown some signs of picking up, and a string of improved data has led economists to look for better growth in the fourth quarter. But the critical driver of growth continues to be the consumer, so holiday sales will be an important indicator to watch.

    Employment data remains the most important of the economic reports, since a strong labor market is crucial for consumer confidence and spending.

    Economists expect the economy added 183,000 jobs in November, according to Refinitiv. The economy added 128,000 jobs in October, even with the negative drag of 46,000 striking GM workers and the reduction of 17,000 federal government jobs, due to the end of temporary employment for Census workers.

    "For the employment report, we think one factor that is likely to result in a slightly stronger headline payroll number is the fact we will now count the GM workers that were on strike," said Barclays economist Pooja Sriram. "We estimated 36,000 to 40,000 were left out of the report in October. We think they're to be counted as part of the November report. Much of that is going to be seen in private payrolls and especially in manufacturing payrolls."

    In October, ISM manufacturing activity improved, and even though it remained in contraction, some economists said the slowdown may be showing signs of bottoming.

    The ISM index is expected to be at 49.4, still shy of 50, which shows expansion, but better than October's 48.3. "We still think it's going to be a sub-50 print," said Sriram.

    October's durable goods report showed a surprise gain in business investment when economists had expected to see contraction.

    Sriram said the speed of decline in manufacturing has certainly slowed, and she is watching the data closely. "I don't think we're comfortable saying we bottomed," she said.

    OPEC and Russia hold meetings in Vienna on Thursday and Friday, and analysts expect them to extend their production cutting agreement. However, Russia may seek to change the rules for how it counts its petroleum output, so the meeting may not be as predictable as expected, some analysts say.

    This past week saw the following moves in the S&P:

    (CLICK HERE FOR THE FULL S&P TREE MAP FOR THE PAST WEEK!)

    Major Indices for this past week:

    (CLICK HERE FOR THE MAJOR INDICES FOR THE PAST WEEK!)

    Major Futures Markets as of Friday's close:

    (CLICK HERE FOR THE MAJOR FUTURES INDICES AS OF FRIDAY!)

    Economic Calendar for the Week Ahead:

    (CLICK HERE FOR THE FULL ECONOMIC CALENDAR FOR THE WEEK AHEAD!)

    Sector Performance WTD, MTD, YTD:

    (CLICK HERE FOR FRIDAY'S PERFORMANCE!)
    (CLICK HERE FOR THE WEEK-TO-DATE PERFORMANCE!)
    (CLICK HERE FOR THE MONTH-TO-DATE PERFORMANCE!)
    (CLICK HERE FOR THE 3-MONTH PERFORMANCE!)
    (CLICK HERE FOR THE YEAR-TO-DATE PERFORMANCE!)
    (CLICK HERE FOR THE 52-WEEK PERFORMANCE!)

    Percentage Changes for the Major Indices, WTD, MTD, QTD, YTD as of Friday's close:

    (CLICK HERE FOR THE CHART!)

    S&P Sectors for the Past Week:

    (CLICK HERE FOR THE CHART!)

    Major Indices Pullback/Correction Levels as of Friday's close:

    (CLICK HERE FOR THE CHART!

    Major Indices Rally Levels as of Friday's close:

    (CLICK HERE FOR THE CHART!)

    Most Anticipated Earnings Releases for this week:

    (CLICK HERE FOR THE CHART!)

    Here are the upcoming IPO's for this week:

    (CLICK HERE FOR THE CHART!)

    Friday's Stock Analyst Upgrades & Downgrades:

    (CLICK HERE FOR THE CHART!)

    Next Week's Economic Indicators - 11/29/19

    Even with a holiday and a shortened session Friday leaving no US releases in the past 48 hours, it was a very busy week for economic data with 36 releases in the first three days. Most of this data came in stronger than expected or above the prior reading where there were no forecasts. While the bulk of the week's data was strong, manufacturing data, namely from the regional Fed indices, was mixed. We started off with a weaker Chicago Fed National Activity Index on Monday. The index fell from -0.45 last month to -0.71 rather than the expected improvement to -0.2. The Dallas Fed's index was also out on Monday and it improved more than expected as well as versus the prior month. On Tuesday, the Richmond Fed's gauge on manufacturing was also worse than expected. On the bright side, other manufacturing hard data like durable goods came in much stronger than both the previous month and consensus forecasts. Housing data was also solid this week with better than anticipated home price growth shown in two of the three indicators: the quarterly Home Price Purchase Index, FHFA, and Case-Shiller (only the Case-Shiller index was weaker than expected, albeit up from the prior month). The second release of third-quarter GDP was the most notable indicator of the week with a much stronger than expected reading which showed the economy grew by 2.1% QoQ versus estimates of a 1.9% growth rate.

    (CLICK HERE FOR THE CHART!)

    We kick off December with another busy few days next week. Final November Markit and ISM numbers will kick off the week on Monday. While Markit is not expecting any change from the preliminary readings, ISM is expected to improve to 49.2 which would still be a contractionary print. In hard manufacturing data, later in the week we will see final durable and capital goods numbers for November. Vehicle sales figures will be the only release on Tuesday followed by the service counterparts to Markit and ISM indices on Wednesday as the rest of the week's main focus will be on labor data. After a surprisingly strong release last month, Nonfarm Payrolls is again expecting a strong print showing 190K jobs created in the month of November.

    (CLICK HERE FOR THE CHART!)

    Stocks To Be The Most Thankful For

    Below is a list of the 25 best performing stocks in the S&P 500 so far in 2019. Advanced Micro Devices (AMD) tops the list with a gain of more than 100%. While no other S&P 500 stocks have yet to double this year, another semi name, Lam Research (LRCX) has come close with a gain of 99%. Xerox (XRX), MarketAxess (MKTX), and Target (TGT) have also all risen more than 90%.

    (CLICK HERE FOR THE CHART!)

    Apple (AAPL) is the 19th best performing stock in the list above. But because of its trillion+ dollar market cap, Apple's (AAPL) 69% gain has a much bigger impact on the overall stock market than all of the other stocks that have seen a bigger price move this year. In fact, of the S&P 500's 25% price gain this year, Apple has accounted for 2.24 of those percentage points (or roughly 9%).

    Instead of looking at simple year-to-date price change, below is a list of the stocks that investors should be most thankful for this year because of their contribution to the S&P's gains. Right behind Apple (AAPL) in first is the other trillion+ dollar company -- Microsoft (MSFT) -- which has accounted for 1.7 percentage points of the S&P's 25% gain. After AAPL and MSFT are Facebook (FB), Alphabet (GOOGL), and Amazon (AMZN). Together these five mega-caps account for 25% of the S&P's move higher this year. While this group of companies has been vilified in 2019 for a number of things, they're certainly still delivering for the stock market in a big way.

    (CLICK HERE FOR THE CHART!)

    S&P 500 Industry Group Breadth Running Strong

    The S&P 500 may be hitting record highs at a pace of more than once every other day, but would you believe that there are still Industry Groups trading below their 50-day moving averages? The chart below shows the rolling percentage of Industry Groups trading above their 50-DMAs over the last several years, and the current reading stands at 91.7%. Over the last five years there have been numerous periods where a higher percentage (and even 100%) of Industry Groups traded above their 50-DMAs, and the most recent was back in July.

    (CLICK HERE FOR THE CHART!)

    So which are the two outlier groups that are still below their 50-DMAs? Well, when everyone seems to be taking an offensive posture in the market, it's only natural that defensive sectors would be lagging, and two of the most defensive-oriented sectors in this yield-hungry world we live in are Utilities and Real Estate. Even these two groups, though, are only about 1% below their 50-DMAs, so all it will take is one or two good days for these groups to get them back over the hump. On the upside, Health Care Equipment & Services is the furthest above its 50-DMA at 7.72%.

    The S&P 500 as a whole is currently just over 4% above its 50-DMA. What's interesting to note here, though, is that just 9 of the 24 Industry Groups are further above their 50-DMAs while 15 are not above their 50-DMAs by as much as the S&P 500. In terms of YTD returns, the S&P 500 is currently sitting on a gain of more than 25% YTD. Leading the way higher this year, Tech Hardware (Apple) has rallied just under 48%, while Semis are up just over 40%. Behind these two leaders, four other Industry Groups are up over 30% YTD. While there is no downside on a YTD basis, Energy has been the biggest laggard and is just barely hanging on to a YTD gain. If Energy can't hang onto a YTD gain in a year where the S&P 500 gains more than 25%, Energy investors may need to wear paper bags over their heads.

    (CLICK HERE FOR THE CHART!)

    Technology Sector P/E Highest in Ten Years

    As equities run to all-time highs, valuations are at a fairly interesting point. As shown in the chart below using data from our Daily Sector Snapshot included with our Morning Lineup and The Closer, most sectors' valuations are at the upper end of the past ten years' range. Four sectors, Consumer Discretionary, Communication Services, Utilities, and Technology all have trailing P/E ratios in the 90th percentile or higher of the past ten years' readings.

    Since the S&P 500 established its first all-time high since July on October 28th, Health Care and Financials have been two of the strongest performers rising 6.68% and 4.35%, respectively. Despite these runs, both of these sectors still have reasonable valuations relative to the past decade. For Financials, the current trailing price-to-earnings ratio is in the 42nd percentile of all days of the past ten years. No other sector has such a low reading although Materials and Energy are on the lower end relative to other sectors. On the other hand, Utilities and Technology have some of the highest valuations of the past ten years with the current P/E in the 97th and 99th percentiles, respectively.

    (CLICK HERE FOR THE CHART!)

    As shown in the chart below, most of the last 9-12 months has seen valuations for Utilities consistently in the uppermost range of the past ten years as investors chased yield in a low interest rate environment. But as risk-free rates have risen more recently, valuations for Utilities have pulled back a bit as price has slid. While there have been other periods in the past ten years where Utilities' P/E ratio was similarly elevated, arguably only 2016/2017 saw it remain at the upper end of the ten-year range as consistently as has been the case this year.

    For Technology it is a whole different story. The P/E for the sector got crushed this time last year and after plummeting to the 31st percentile, it is has rebounded to the highest levels of the past ten years. The only other time that the sector traded at a similar premium relative to the past decade's range was back in early 2018.

    (CLICK HERE FOR THE CHART!)

    Thanksgiving through Santa Claus Rally Trade

    Everyone is talking about yearend seasonal strength this year, but it's not news to us. 2019 has been tracking historical seasonal market patterns quite closely this year and that suggests it is likely to continue to track it.

    Our good friend Larry McMillan (@optstrategist) trades seasonal yearend strength with the Russell 2000 from the close the day before Thanksgiving through the end of our Santa Claus Rally (the last five trading days of the year and the first two trading days of the New Year).

    So here we have run the numbers from 1979 when the Russell index data begins comparing R2K to the DJIA, S&P 500 and NASDAQ. The small-cap index Russell 2000 is the best performer up an average 3.1% (median 3.2%) with an 80% win ratio up 32 of the last 40 years. Last year was the worst and it's been down 3 of the last 5 years.

    (CLICK HERE FOR THE CHART!)

    Giving Thanks for the U.S. Consumer

    This Thanksgiving, we're thankful for solid consumer confidence, even though it has wavered in recent months.

    Consumer confidence fell for a fourth straight month in November, according to preliminary Conference Board data. Even though the Conference Board's Consumer Confidence Index has dropped from its economic cycle peak, consumer sentiment is still historically elevated, as shown in the LPL Chart of the Day.

    (CLICK HERE FOR THE CHART!)

    We've been pleasantly surprised by the U.S. consumer's resilience over the past year as other parts of the domestic economy have weakened amid global headwinds. Strong consumer spending has helped the economy grow at a 2% average rate over the past two quarters, despite drags on growth from business spending, inventories, and trade.

    "Consumer sentiment has been largely immune from global headwinds," said LPL Financial Senior Market Strategist Ryan Detrick. "We expect consumer spending to power economic growth through next year, so we'd like to see consumer confidence pick up more with signs of trade progress."

    Consumers have several reasons to be optimistic. Employment is the primary driver of consumer health, and the U.S. labor market has been resilient. Wages are growing at a healthy rate, and consumers are reaping the benefits of tax cuts and record-high stock prices. As long as the job market stays solid and inflation remains in check, we feel good about consumers' prospects.

    Still, there are growing signs of concern. While survey respondents have remained optimistic about present conditions, their outlook on future conditions has soured, according to the Conference Board. If consumers are feeling less confident about the future, they may be less inclined to spend and invest. That loss of confidence in the outlook could lead to economic weakness over time if consumers step back.

    Overall, we would need to see more significant deterioration in consumer confidence before we would start to worry about the economic outlook.

    STOCK MARKET VIDEO: Stock Market Analysis Video for Week Ending November 29th, 2019

    ([CLICK HERE FOR THE YOUTUBE VIDEO!]())

    (VIDEO NOT YET POSTED!)

    STOCK MARKET VIDEO: ShadowTrader Video Weekly 12.1.19

    ([CLICK HERE FOR THE YOUTUBE VIDEO!]())

    (VIDEO NOT YET POSTED!)

    Here are the most notable companies (tickers) reporting earnings in this upcoming trading week ahead-

    • $CRM
    • $DG
    • $ULTA
    • $COUP
    • $MRVL
    • $WDAY
    • $ZS
    • $RH
    • $OKTA
    • $TIF
    • $CRWD
    • $KR
    • $CLDR
    • $DSX
    • $WORK
    • $BMO
    • $ZM
    • $CPB
    • $FIVE
    • $QTT
    • $DOCU
    • $MIK
    • $TD
    • $YJ
    • $LE
    • $AVAV
    • $RY
    • $SNPS
    • $HQY
    • $DCI
    • $BIG
    • $GSM
    • $SIG
    • $SMAR
    • $GIII
    • $HOME
    • $HRB
    • $DLTH
    • $TLYS
    • $ZUO
    • $GEF
    • $JW.A
    • $GMS
    • $EXPR
    • $ZUMZ
    (CLICK HERE FOR NEXT WEEK'S MOST NOTABLE EARNINGS RELEASES!)
    (CLICK HERE FOR NEXT WEEK'S HIGHEST VOLATILITY EARNINGS RELEASES!)
    (CLICK HERE FOR MOST ANTICIPATED EARNINGS RELEASES FOR THE NEXT 5 WEEKS!)

    Below are some of the notable companies coming out with earnings releases this upcoming trading week ahead which includes the date/time of release & consensus estimates courtesy of Earnings Whispers:

    Monday 12.2.19 Before Market Open:

    (CLICK HERE FOR MONDAY'S PRE-MARKET EARNINGS TIME & ESTIMATES!)

    Monday 12.2.19 After Market Close:

    (CLICK HERE FOR MONDAY'S AFTER-MARKET EARNINGS TIME & ESTIMATES!)

    Tuesday 12.3.19 Before Market Open:

    (CLICK HERE FOR TUESDAY'S PRE-MARKET EARNINGS TIME & ESTIMATES!)

    Tuesday 12.3.19 After Market Close:

    (CLICK HERE FOR TUESDAY'S AFTER-MARKET EARNINGS TIME & ESTIMATES!)

    Wednesday 12.4.19 Before Market Open:

    (CLICK HERE FOR WEDNESDAY'S PRE-MARKET EARNINGS TIME & ESTIMATES!)

    Wednesday 12.4.19 After Market Close:

    (CLICK HERE FOR WEDNESDAY'S AFTER-MARKET EARNINGS TIME & ESTIMATES!)

    Thursday 12.5.19 Before Market Open:

    (CLICK HERE FOR THURSDAY'S PRE-MARKET EARNINGS TIME & ESTIMATES!)

    Thursday 12.5.19 After Market Close:

    (CLICK HERE FOR THURSDAY'S AFTER-MARKET EARNINGS TIME & ESTIMATES!)

    Friday 12.6.19 Before Market Open:

    (CLICK HERE FOR FRIDAY'S PRE-MARKET EARNINGS TIME & ESTIMATES!)

    Friday 12.6.19 After Market Close:

    ([CLICK HERE FOR FRIDAY'S AFTER-MARKET EARNINGS TIME & ESTIMATES!]())

    NONE.

    Salesforce $162.89

    Salesforce (CRM) is confirmed to report earnings at approximately 4:05 PM ET on Tuesday, December 3, 2019. The consensus earnings estimate is $0.66 per share on revenue of $4.44 billion and the Earnings Whisper ® number is $0.69 per share. Investor sentiment going into the company's earnings release has 77% expecting an earnings beat The company's guidance was for earnings of $0.65 to $0.66 per share. Consensus estimates are for year-over-year earnings growth of 8.20% with revenue increasing by 30.90%. Short interest has decreased by 48.0% since the company's last earnings release while the stock has drifted higher by 3.3% from its open following the earnings release to be 5.4% above its 200 day moving average of $154.54. Overall earnings estimates have been revised lower since the company's last earnings release. On Monday, November 25, 2019 there was some notable buying of 1,252 contracts of the $162.50 call expiring on Friday, December 6, 2019. Option traders are pricing in a 4.5% move on earnings and the stock has averaged a 3.7% move in recent quarters.

    (CLICK HERE FOR THE CHART!)

    Dollar General Corporation $157.36

    Dollar General Corporation (DG) is confirmed to report earnings at approximately 6:30 AM ET on Thursday, December 5, 2019. The consensus earnings estimate is $1.38 per share on revenue of $6.91 billion and the Earnings Whisper ® number is $1.39 per share. Investor sentiment going into the company's earnings release has 77% expecting an earnings beat. Consensus estimates are for year-over-year earnings growth of 9.52% with revenue increasing by 7.67%. Short interest has decreased by 1.8% since the company's last earnings release while the stock has drifted higher by 3.8% from its open following the earnings release to be 14.0% above its 200 day moving average of $138.01. Overall earnings estimates have been revised higher since the company's last earnings release. On Wednesday, November 27, 2019 there was some notable buying of 574 contracts of the $100.00 put expiring on Friday, December 20, 2019. Option traders are pricing in a 6.3% move on earnings and the stock has averaged a 7.1% move in recent quarters.

    (CLICK HERE FOR THE CHART!)

    ULTA Beauty $233.86

    ULTA Beauty (ULTA) is confirmed to report earnings at approximately 4:00 PM ET on Thursday, December 5, 2019. The consensus earnings estimate is $2.14 per share on revenue of $1.69 billion and the Earnings Whisper ® number is $2.17 per share. Investor sentiment going into the company's earnings release has 61% expecting an earnings beat. Consensus estimates are for earnings to decline year-over-year by 1.83% with revenue increasing by 8.33%. Short interest has increased by 1.8% since the company's last earnings release while the stock has drifted lower by 7.5% from its open following the earnings release to be 23.5% below its 200 day moving average of $305.86. Overall earnings estimates have been revised lower since the company's last earnings release. On Friday, November 22, 2019 there was some notable buying of 1,992 contracts of the $200.00 put expiring on Friday, January 17, 2020. Option traders are pricing in a 8.7% move on earnings and the stock has averaged a 9.9% move in recent quarters.

    (CLICK HERE FOR THE CHART!)

    Coupa Software $153.49

    Coupa Software (COUP) is confirmed to report earnings at approximately 4:05 PM ET on Monday, December 2, 2019. The consensus earnings estimate is $0.06 per share on revenue of $96.50 million and the Earnings Whisper ® number is $0.10 per share. Investor sentiment going into the company's earnings release has 70% expecting an earnings beat The company's guidance was for earnings of $0.05 to $0.08 per share on revenue of $96.00 million to $96.00 million. Consensus estimates are for earnings to decline year-over-year by 53.85% with revenue increasing by 43.06%. Short interest has increased by 74.3% since the company's last earnings release while the stock has drifted higher by 2.7% from its open following the earnings release to be 26.1% above its 200 day moving average of $121.76. Overall earnings estimates have been revised lower since the company's last earnings release. On Friday, November 29, 2019 there was some notable buying of 679 contracts of the $172.50 call expiring on Friday, December 6, 2019. Option traders are pricing in a 9.8% move on earnings and the stock has averaged a 8.1% move in recent quarters.

    (CLICK HERE FOR THE CHART!)

    Marvell Technology Group Ltd. $26.37

    Marvell Technology Group Ltd. (MRVL) is confirmed to report earnings at approximately 4:05 PM ET on Tuesday, December 3, 2019. The consensus earnings estimate is $0.17 per share on revenue of $660.23 million and the Earnings Whisper ® number is $0.19 per share. Investor sentiment going into the company's earnings release has 65% expecting an earnings beat The company's guidance was for earnings of $0.15 to $0.19 per share on revenue of $640.00 million to $680.00 million. Consensus estimates are for earnings to decline year-over-year by 55.26% with revenue decreasing by 22.42%. Short interest has increased by 25.8% since the company's last earnings release while the stock has drifted higher by 9.4% from its open following the earnings release to be 9.5% above its 200 day moving average of $24.08. Overall earnings estimates have been revised lower since the company's last earnings release. On Friday, November 15, 2019 there was some notable buying of 1,289 contracts of the $29.00 call expiring on Friday, May 15, 2020. Option traders are pricing in a 6.6% move on earnings and the stock has averaged a 1.8% move in recent quarters.

    (CLICK HERE FOR THE CHART!)

    Workday, Inc. $179.12

    Workday, Inc. (WDAY) is confirmed to report earnings at approximately 4:00 PM ET on Tuesday, December 3, 2019. The consensus earnings estimate is $0.37 per share on revenue of $918.63 million and the Earnings Whisper ® number is $0.40 per share. Investor sentiment going into the company's earnings release has 64% expecting an earnings beat The company's guidance was for revenue of $918.00 million to $920.00 million. Consensus estimates are for year-over-year earnings growth of 640.00% with revenue increasing by 23.61%. Short interest has increased by 5.2% since the company's last earnings release while the stock has drifted lower by 2.7% from its open following the earnings release to be 5.1% below its 200 day moving average of $188.76. Overall earnings estimates have been revised lower since the company's last earnings release. On Monday, November 18, 2019 there was some notable buying of 1,895 contracts of the $160.00 put expiring on Friday, December 20, 2019. Option traders are pricing in a 6.4% move on earnings and the stock has averaged a 26.0% move in recent quarters.

    (CLICK HERE FOR THE CHART!)

    Zscaler, Inc. $52.13

    Zscaler, Inc. (ZS) is confirmed to report earnings at approximately 4:05 PM ET on Tuesday, December 3, 2019. The consensus earnings estimate is $0.01 per share on revenue of $89.34 million and the Earnings Whisper ® number is $0.03 per share. Investor sentiment going into the company's earnings release has 75% expecting an earnings beat The company's guidance was for results to range from breakeven to earnings of $0.01 per share on revenue of $89.00 million to $90.00 million. Consensus estimates are for year-over-year earnings growth of 200.00% with revenue increasing by 41.14%. Short interest has increased by 110.8% since the company's last earnings release while the stock has drifted higher by 7.8% from its open following the earnings release to be 18.7% below its 200 day moving average of $64.13. Overall earnings estimates have been revised higher since the company's last earnings release. On Tuesday, November 12, 2019 there was some notable buying of 2,720 contracts of the $47.00 call expiring on Friday, January 17, 2020. Option traders are pricing in a 14.2% move on earnings and the stock has averaged a 15.2% move in recent quarters.

    (CLICK HERE FOR THE CHART!)

    RH $205.59

    RH (RH) is confirmed to report earnings at approximately 4:15 PM ET on Wednesday, December 4, 2019. The consensus earnings estimate is $2.21 per share on revenue of $675.57 million and the Earnings Whisper ® number is $2.35 per share. Investor sentiment going into the company's earnings release has 69% expecting an earnings beat. Consensus estimates are for year-over-year earnings growth of 27.75% with revenue increasing by 6.13%. Short interest has increased by 14.1% since the company's last earnings release while the stock has drifted higher by 32.3% from its open following the earnings release to be 49.3% above its 200 day moving average of $137.69. Overall earnings estimates have been revised higher since the company's last earnings release. Option traders are pricing in a 13.0% move on earnings and the stock has averaged a 16.2% move in recent quarters.

    (CLICK HERE FOR THE CHART!)

    Okta, Inc. $129.78

    Okta, Inc. (OKTA) is confirmed to report earnings at approximately 4:05 PM ET on Thursday, December 5, 2019. The consensus estimate is for a loss of $0.12 per share on revenue of $143.45 million and the Earnings Whisper ® number is ($0.10) per share. Investor sentiment going into the company's earnings release has 69% expecting an earnings beat The company's guidance was for a loss of $0.13 to $0.12 per share on revenue of $143.00 million to $144.00 million. Consensus estimates are for earnings to decline year-over-year by 220.00% with revenue increasing by 35.87%. Short interest has increased by 25.4% since the company's last earnings release while the stock has drifted lower by 0.7% from its open following the earnings release to be 17.2% above its 200 day moving average of $110.74. Overall earnings estimates have been revised lower since the company's last earnings release. On Wednesday, November 27, 2019 there was some notable buying of 549 contracts of the $170.00 call expiring on Friday, May 15, 2020. Option traders are pricing in a 8.7% move on earnings and the stock has averaged a 8.3% move in recent quarters.

    (CLICK HERE FOR THE CHART!)

    Tiffany & Co. $133.80

    Tiffany & Co. (TIF) is confirmed to report earnings at approximately 6:40 AM ET on Thursday, December 5, 2019. The consensus earnings estimate is $0.85 per share on revenue of $1.04 billion. Investor sentiment going into the company's earnings release has 65% expecting an earnings beat. Consensus estimates are for year-over-year earnings growth of 10.39% with revenue increasing by 2.73%. Short interest has decreased by 38.0% since the company's last earnings release while the stock has drifted higher by 69.6% from its open following the earnings release to be 36.1% above its 200 day moving average of $98.28. Overall earnings estimates have been revised lower since the company's last earnings release. On Thursday, November 14, 2019 there was some notable buying of 3,427 contracts of the $100.00 put expiring on Friday, February 21, 2020. Option traders are pricing in a 0.5% move on earnings and the stock has averaged a 7.5% move in recent quarters.

    (CLICK HERE FOR THE CHART!)

    DISCUSS!

    What are you all watching for in this upcoming trading week?

    I hope you all have a wonderful weekend and a great trading week ahead r/stocks.

    submitted by /u/bigbear0083
    [link] [comments]

    WHERE to park money while saving for house (2-3 year horizon)

    Posted: 29 Nov 2019 03:57 PM PST

    Where would you park your money at low or medium risk, for a 2-3 year horizon, with the goal to get a better return than a CD?

    submitted by /u/maxgw18
    [link] [comments]

    Tesla

    Posted: 30 Nov 2019 01:15 PM PST

    All of Elon Musk companies, Tesla, Space X, Solar city, and what ever else. Are all those companies under Tesla stock?

    submitted by /u/Bvlts
    [link] [comments]

    I want to invest all my money into Cronos, why shouldn't I?

    Posted: 29 Nov 2019 10:31 PM PST

    It's sititng at $6.85 when it used to be at $23.70 earlier this year in March.

    Any reason I shouldn't buy this then wait for it to skyrocket once weed is legalized federally?

    submitted by /u/The_Madmans_Reign
    [link] [comments]

    North American Palladium - Impala Takeover - Strategy

    Posted: 30 Nov 2019 08:46 AM PST

    Hi, so PDL will be performing a vote on the 4th as to whether or not to accept the very low bid from Impala, I have been watching this stock for a while and they have really turned things around in recent years, however, it seems upper management want to get out. So they are considering a Impala takeover bid, since PDL hold most of the shares it seems that the vote on the 4th has already been decided and they will just accept. However my feeling is there is a small chance that someone else will come in and offer a higher bid.

    Based on the above I was considering putting in a limit order at above the current maket price of $19.75 CAD since that is what the bid is. Assuming this goes through on the 4th my limit order will not go through and I will loose nothing, however if someone else comes along and puts in a higher bid the market will react and the price will be pushed up to the new bid. This seems like a no brainer for me, but I am new to this and I am probably missing something...

    submitted by /u/alexisonsmith
    [link] [comments]

    Does TD Ameritrade insure you against technical issues?

    Posted: 30 Nov 2019 12:21 PM PST

    I made a large purchase with the app and have not been able to log in to the app (reset password dozens of times and tried the website dozens of times), and their tech support couldn't fix it. I just found out my trade didn't go through now. They said I have to call back Monday when the programmers are back.

    The stock is now trading a few hundred dollars higher than amount I had purchased. Do they offer protection over their system not functioning correctly?

    submitted by /u/Aspanu24
    [link] [comments]

    How can you find out who are the largest individual shareholders of a company?

    Posted: 30 Nov 2019 12:20 PM PST

    I know it is pretty easy to figure out who are the largest institutional shareholders but I can't seem to find much info regarding individual shareholders.

    Warren Buffet is said to own about 18% of Berkshire Hathaway. How can I verify this?

    submitted by /u/951052736
    [link] [comments]

    Virgin galactic

    Posted: 30 Nov 2019 07:53 AM PST

    It's literally only $7 why shouldn't I'm invest. Surely it's gonna make money when it launches

    submitted by /u/justatypicalyute
    [link] [comments]

    Are insiders allowed to buy and sell on the same day through 10b51, as long as it is a net sale?

    Posted: 29 Nov 2019 02:32 PM PST

    Does anybody know the legalities of this? Kalanick has been selling millions of UBER shares for weeks every day, and it appears he is exiting his entire position.

    Someone has been propping the stock every single morning before Kalanick's sell program kicks in. Obviously, Kalanick is only reporting sales.

    Are insiders, or the broker of an insider, legally allowed to act as a 'market maker' if you will, to stimulate a security as they exit the position? Or would they need to report the purchases as well even if at the end of each day it was a net sale?

    Curious

    submitted by /u/professordurian
    [link] [comments]

    Stocks you're looking to buy for 2020 and why?

    Posted: 30 Nov 2019 03:08 AM PST

    As volatility is expected to continue spiking, what stocks will you be looking to buy? What price target would you buy in? Personally I won't be adding more To my portfolio until there is a substantial drop as most stocks are overvalued and I don't see many stocks that are undervalued. Curious to hear everyone's thoughts!

    submitted by /u/Aaronacorona
    [link] [comments]

    Assuming you buy and never sell in a taxable account, what are the tax implications of an extremely high turnover ETF (ticker UTRN) that turns over its entire 25 holdings every week that earns a high positive return?

    Posted: 29 Nov 2019 03:45 PM PST

    Assuming you buy and never sell in a taxable account, what are the tax implications of an extremely high turnover ETF (ticker UTRN) that turns over its entire 25 holdings every week that earns a high positive return? I believe such a high turnover ETF would need to distribute short-term capital gains to its shareholders but I'm having trouble confirming this. Thanks in advance!

    submitted by /u/silly321
    [link] [comments]

    Question about bonds

    Posted: 30 Nov 2019 02:33 AM PST

    I'm new to all of this and am kind of confused haha - i see everyone discussing the impact of interest rates on. Ones but if you buy bonds and are prepared to wait until full maturation to be repaid by the issuer, do you really need to worry about interest rates? What if you are buying from someone else and not the issuer (but are still going to wait until full maturation) should you buy when interest rates are low or is this only if you intend to trade them later? Thanks!

    submitted by /u/pinkpez
    [link] [comments]

    AUPH

    Posted: 29 Nov 2019 02:33 PM PST

    How do I invest in AUPH? Is it in the Toronto stock exchange or Tokyo stock exchange?

    submitted by /u/thomaswujek
    [link] [comments]

    Mall REITs

    Posted: 29 Nov 2019 03:00 PM PST

    What does everybody think of mall REITs right now? Everybody seems to absolutely hate them right now. I feel like they're much more profitable than people think, failing to take into account joint ventures. They're all sitting right around their 52 week lows with massive dividend yields closing in and in some cases breaking 10% yield. Online shopping seems to have more or less capped out on how much it's disrupting malls at the moment. They've weathered the storm and adapted.

    submitted by /u/PiesInMyEyes
    [link] [comments]

    Why is Netflix so highly regarded and why is it included in FAANG?

    Posted: 29 Nov 2019 09:49 PM PST

    It's always easier to look back retrospectively but for years, I have never understood why people go nuts over Netflix. Facebook, Amazon, Apple, and Google all have gigantic moats for their business models and are highly profitable. Meanwhile, Netflix had an okay business model for a few years while it had a head start but is now falling behind. Am I missing some major piece of information here or something? I understand they're trying to make content and everything but imo, it's too little too late. With AppleTV and Disney+ both having massive capability and cash for churning out content and reach out to consumers, what does Netflix still have?

    Basically, I feel like I'm missing something in regards to why Netflix is highly regarded despite their growing competitors and failure of distinction. It's as if people are buying Netflix in the hopes that they get bought out by another company.

    submitted by /u/Jas1052
    [link] [comments]

    I lost 550$ I can't afford to lose in trading

    Posted: 30 Nov 2019 09:39 AM PST

    Hi. You can't imagine being poor and losing 550$ you worked hard for because of your emotions and trying to make a decent money to save your family. I am on the verge to explode and lose my mind because I have lost this amount of money, that might seem ridiculous to you, while trading Forex and I regret it. Living is definitely not for me and I deserve to die because of my failures. I hope someone would feel me out here and help me get it back by donating to me and I would be grateful forever. Poverty is the main issue among people who really want to be traders and make it to the top, because you don't have the right amount of capital to trade with, and having a family to think about feeding at the same time. I'm so lost.

    submitted by /u/Y0ns
    [link] [comments]

    How to learn day-trading?

    Posted: 29 Nov 2019 06:46 PM PST

    Trying the stock market as a hobby/side job, have some experience and would like to know where I can learn to analyze graphs and volume etc for day trading

    submitted by /u/StatusMlgs
    [link] [comments]

    Prospective Stock: Cancer Genetics Inc

    Posted: 29 Nov 2019 06:13 PM PST

    I am a beginner investor, and invested about $100 into this company around a month and a half ago before the reverse split. I am a young teenager so I can't go very far with real money so I experimented with penny stocks. I originally bought the stock when it was $.12, it then later had a 1-30 reverse split and started to progressively go down. It should have been around $4.20 if I wanted my money back. It ended up going all the way down to $2 when they sought a professional adviser. From there it has gone up since and today peaked up to $8.81. I have over doubled the amount of cash I originally put it. So it would be worth a bit of your time to go check out. On a side note, can any experienced investors tell me if they think I should sell and collect my earnings, or keep it as there is a good chance it will stay stable and continue going up?

    submitted by /u/Duck_Butt17
    [link] [comments]
    Read more
    at

    No comments:

    Post a Comment